We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

198 hedge funds and large institutions have $1.22B invested in Immunogen Inc in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 55

11% more capital invested

Capital invested by funds: $1.1B → $1.22B (+$119M)

1% more call options, than puts

Call options by funds: $8.07M | Put options by funds: $8.01M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 204 → 198 (-6)

13% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 32

Holders
198
Holders Change
-6
Holders Change %
-2.94%
% of All Funds
4.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
74
Reduced
55
Closed
32
Calls
$8.07M
Puts
$8.01M
Net Calls
+$54K
Net Calls Change
+$18.7M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$41.4M
2
RG
Redmile Group
California
+$27.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.3M
4
BlackRock
BlackRock
New York
+$21.9M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$21.7M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$17.6M
2
Millennium Management
Millennium Management
New York
-$14.5M
3
Franklin Resources
Franklin Resources
California
-$9.86M
4
Invesco
Invesco
Georgia
-$7.69M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$7.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
176
PNC Financial Services Group
Pennsylvania
$2K -$1.31K -124 -36%
AssetMark Inc
177
AssetMark Inc
California
$2K – – –
CFA
178
Carroll Financial Associates
North Carolina
$2K – – –
CAW
179
Cornerstone Advisors (Washington)
Washington
$2K – – –
HMS
180
Hanseatic Management Services
New Mexico
$2K – – –
HNB
181
Huntington National Bank
Ohio
$2K – – –
TC
182
Trilogy Capital
California
$2K – – –
GRP
183
Global Retirement Partners
California
$2K +$1.28K +121 +138%
TFS
184
TrustCore Financial Services
Tennessee
$2K +$1.78K +169 New
FHA
185
Flagship Harbor Advisors
Massachusetts
$2K +$3.16K +300 New
FHA
186
First Horizon Advisors
Tennessee
$1K – – –
FWM
187
Focused Wealth Management
New York
$1K – – –
GWM
188
Geneos Wealth Management
Colorado
$1K – – –
GFP
189
Gryphon Financial Partners
Ohio
$1K – – –
OIA
190
OneDigital Investment Advisors
Kansas
$1K – – –
SIM
191
Sonora Investment Management
Arizona
$1K +$580 +55 New
AC
192
Avestar Capital
New York
$1K +$1.91K +181 +16%
APA
193
American Portfolios Advisors
New York
$487 – – –
RCAG
194
Rehmann Capital Advisory Group
Michigan
$467 – – –
PC
195
PointState Capital
New York
– -$17.6M -1,673,799 Closed
Arrowstreet Capital
196
Arrowstreet Capital
Massachusetts
– -$7.26M -690,445 Closed
EI
197
EAM Investors
California
– -$3.95M -375,205 Closed
TI
198
Trexquant Investment
Connecticut
– -$3.48M -331,215 Closed
BIM
199
Bogle Investment Management
Massachusetts
– -$2.87M -272,592 Closed
Two Sigma Investments
200
Two Sigma Investments
New York
– -$2.35M -223,216 Closed
6 7
8
9 10

IMGN Hedge Fund Activity: Q2 2018 in Review

198 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2018, worth a combined $1.22B — up 11% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IMGN and 28 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 74 added.

The largest buyer was Capital Research Global Investors, adding an estimated $41.4M. The largest seller was PointState Capital, exiting entirely with an estimated $17.6M sold.

  • 198 institutional investors held Immunogen Inc (IMGN) as of Q2 2018, down from 204 in Q1 2018.
  • Funds reported $1.22B of Immunogen Inc stock for Q2 2018, up 11% quarter-over-quarter.
  • 28 funds opened new Immunogen Inc positions in Q2 2018 and 32 closed out, a net change of -4 holders.
  • The largest Immunogen Inc buyer in Q2 2018 was Capital Research Global Investors, an estimated $41.4M added.
  • The largest Immunogen Inc seller in Q2 2018 was PointState Capital, an estimated $17.6M sold.

Based on aggregated 13F filings for Q2 2018.